dijous, 14 d’abril del 2016

MassDevice.com +5 | The top 5 medtech stories for April 14, 2016

plus5-node

Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.

Get this in your inbox everyday by subscribing to our newsletters.

 

5. Fresenius rebrands dialysis division to Fresenius Kidney Care

MassDevice.com news

Fresenius Medical Care said yesterday it rebranded its dialysis service division under the new name Fresenius Kidney Care.

With the move, Waltham, Mass.-based said it launched a new website for the business which offers education on dialysis, treatment options and other tailored information for people in various stages of kidney disease, the company said. Read more


4. Battelle’s NeuroLife uses thought to control paralyzed limbs

MassDevice.com news

Researchers at Battelle today published a paper in Nature covering the progress of its NeuroLife system, implanted in quadriplegic patient Ian Burkhart. In 2014, Burkhart became the 1st patient ever to achieve motor control of his paralyzed arms and hands through his own thoughts.

The NeuroLife system restored enough motion for Burkhart to perform tasks such as pouring out bottles, mixing liquids and taking a credit card from his wallet and swiping it. Burkhart, a quadriplegic, was injured in a 2010 diving accident that paralyzed him from the chest down. Read more


3. CryoLife buys Genesee BioMed’s PhotoFix pericardium patch

MassDevice.com news

CryoLife Inc. said today it exercised its right to acquire Genesee BioMedical’s PhotoFix bovine pericardium patch for $2.3 million in cash.

Atlanta, Ga.-based Cryolife said it had the option to purchase the patches after acquiring the distribution rights and a purchase option for PhotoFix in August 2014. Read more


2. RefleXion closes $46m Series B

MassDevice.com news

California-based medtech group RefleXion Medical said today it closed a $46 million Series B round of financing, with funds slated to expand its engineering, regulatory and commercial organizations.

RefleXion Medical said it is developing a biology-guided radiotherapy system for cancer treatment, which is designed to use positron emission tomography to locate and identify tumors during treatments. Read more


1. Report: Feds impanel grand jury in Boston Scientific pelvic mesh probe

MassDevice.com news

A federal probe into allegations that Boston Scientific used counterfeit resin to make pelvic mesh products has reportedly convened a grand jury in West Virginia that’s already sent out several subpoenas.

The accusations 1st surfaced in January with the filing of a purported class-action racketeering lawsuit in the U.S. District Court for Southern West Virginia, the venue for multi-district litigation against a clutch of companies over their respective mesh products for treating female urinary incontinence and pelvic organ prolapse. Read more

The post MassDevice.com +5 | The top 5 medtech stories for April 14, 2016 appeared first on MassDevice.



from MassDevice http://ift.tt/23IxgvH

Cap comentari:

Publica un comentari a l'entrada